Becton Dickinson PE Ratio 2006-2018 | BDX

Current and historical p/e ratio for Becton Dickinson (BDX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Becton Dickinson PE ratio as of April 22, 2019 is 20.37.
Becton Dickinson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-22 225.04 69.24
2018-12-31 225.32 $3.25 69.33
2018-09-30 260.15 $0.44 591.24
2018-06-30 238.08 $2.32 102.62
2018-03-31 214.66 $-0.46 0.00
2017-12-31 211.33 $1.31 161.32
2017-09-30 192.79 $4.65 41.46
2017-06-30 191.26 $3.50 54.65
2017-03-31 179.15 $6.05 29.61
2016-12-31 161.04 $6.03 26.71
2016-09-30 174.05 $4.51 38.59
2016-06-30 163.63 $5.26 31.11
2016-03-31 145.91 $3.75 38.91
2015-12-31 147.43 $3.27 45.09
2015-09-30 126.39 $3.41 37.06
2015-06-30 134.35 $4.10 32.77
2015-03-31 135.61 $5.46 24.84
2014-12-31 130.89 $5.83 22.45
2014-09-30 106.59 $6.00 17.76
2014-06-30 110.27 $4.93 22.37
2014-03-31 108.64 $4.80 22.63
2013-12-31 102.04 $4.74 21.53
2013-09-30 91.91 $6.50 14.14
2013-06-30 90.36 $7.47 12.10
2013-03-31 86.97 $7.54 11.54
2012-12-31 70.73 $7.54 9.38
2012-09-30 70.61 $5.62 12.56
2012-06-30 66.79 $5.55 12.03
2012-03-31 68.96 $5.49 12.56
2011-12-31 65.96 $5.48 12.04
2011-09-30 64.33 $5.63 11.43
2011-06-30 75.22 $5.95 12.64
2011-03-31 69.17 $5.71 12.11
2010-12-31 73.05 $5.57 13.11
2010-09-30 63.72 $5.51 11.56
2010-06-30 57.84 $5.12 11.30
2010-03-31 66.99 $5.22 12.83
2009-12-31 66.78 $5.04 13.25
2009-09-30 58.79 $5.00 11.76
2009-06-30 59.82 $4.83 12.39
2009-03-31 56.13 $4.62 12.15
2008-12-31 56.80 $4.65 12.21
2008-09-30 66.31 $4.46 14.87
2008-06-30 66.95 $4.33 15.46
2008-03-31 70.45 $4.11 17.14
2007-12-31 68.37 $3.97 17.22
2007-09-30 66.89 $3.46 19.33
2007-06-30 60.54 $3.15 19.22
2007-03-31 62.28 $3.00 20.76
2006-12-31 56.63 $2.65 21.37
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $61.317B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $22.518B 57.33
McKesson (MCK) United States $21.887B 8.52
AmerisourceBergen (ABC) United States $15.293B 11.09
Laboratory Of America Holdings (LH) United States $14.330B 13.18
Cooper (COO) United States $13.885B 24.22
Cardinal Health (CAH) United States $13.709B 9.24
DENTSPLY SIRONA (XRAY) United States $11.127B 24.74
Henry Schein (HSIC) United States $9.192B 14.86
West Pharmaceutical Services (WST) United States $8.223B 39.69
Merit Medical Systems (MMSI) United States $3.170B 34.12
CONMED (CNMD) United States $2.242B 36.43
Patterson (PDCO) United States $2.031B 16.05
Atrion (ATRI) United States $1.612B 47.31
STAAR Surgical (STAA) United States $1.380B 115.59
Antares Pharma (ATRS) United States $0.437B 0.00
Invacare (IVC) United States $0.222B 0.00
Lifevantage (LFVN) United States $0.158B 21.27
Pro-Dex (PDEX) United States $0.063B 28.64
Endologix (ELGX) United States $0.060B 0.00
Biolase (BIOL) United States $0.049B 0.00